Ambroxol 15mg Manufacturers and PCD Company – Associate with Luckys Pharma to grab quality ambroxol medicine under contract manufacturing. Luckys Pharma is a professional manufacturer and supplier of ambroxol 15mg tablets to help clients establish businesses in the pharmaceutical sector. It is the leading ambroxol 15mg manufacturer and PCD franchise company in India.

Business associates can approach the firm by contacting at 08889909734 or writing to info@luckyspharma.com
Ambroxol is a mucolytic drug that is prescribed to treat respiratory tract disorders. The mucolytic agent starts delivering results around 30 minutes after the tablet is swallowed orally. It acts by degrading the fibers of acid mucopolysaccharide. Further, the medicine turns the sputum thinner and makes it less viscous to make it easier for coughing to extract.
Dosage
The ambroxol dose is crucial to conquering the targeted motive. Physicians prescribe ambroxol in terms of the following dosages –
Ambroxol tablets are used to get rid of conditions such as shortened breath, inflammation of lung airways, and constant cough. This medicine is effective in the symptomatic treatment of tracheobronchitis and some infections. Moreover, ambroxol helps patients dealing with an excessive cough and thick sputum.
Ambroxol delivers qualitative treatment policies against conditions such as severe cough and thick sputum. A gargantuan chunk of the Indian population witnesses critical lung and respiratory-related diseases. These scenarios further cause dreadful health concerns such as asthma and cancer. Thereby, there is a big demand for effective medications like ambroxol in Indian markets to combat critical respiratory disorders.
Business Outlook
Business enterprises can invest in the pharmaceutical domain for ambroxol medications to conclude impeccable growth and prosperity. Given the demand graph is going high in India, it is thoughtful to venture into the ambroxol business to generate huge profitability and success. For this purpose, startups can associate with an established PCD franchise company like Luckys Pharma to get finished ambroxol 15mg tablets.
|
Market demand for Ambroxol and Cough syrups in India as per Market Research |
The Indian cough syrup market is expected to grow from USD 349 million to USD 654 million by 2035, with a CAGR of around 6.4%. |
|
Another report from Statista |
The overall cold and cough remedies market in India is valued at USD 1.56 billion in 2025, which is growing steadily. |
Reasons for increasing market demand and growth are:
This indicates the strong growth includes long term business opportunity.
It is widely prescribed because it helps in breaking mucus, improving breathing and treating bronchitis and respiratory infections, which is why this makes it a high-prescription and fast-moving product. The reasons for rising respiratory problems in India are:
Luckys Pharma is the one-stop destination if you’re looking for the top-ranked ambroxol 15mg third-party manufacturer in India. Since its evolution in 2001, the ISO 9001:2015 certified brand has registered remarkable growth in the Indian pharmaceutical circuit. Alongside producing and supplying high-quality pharma products, it also nurtures new businesses with supportive PCD franchise services across versatile therapeutics.
In terms of ambroxol 15mg medication, Luckys Pharma is a qualified manufacturer, supplier, trader and marketer of the drug. The company installs advanced manufacturing units and deploys innovative technologies to formulate something extraordinary for patients, individuals, health institutions and business associates.
Other Popular Developments –
In addition to ambroxol, Luckys Pharma also has the proficiency to develop a diverse range of other pharmaceutical products and equipment. Have a look.
|
Tablets |
Injectables |
Capsules |
Rotacaps |
Respules |
|
Sprays |
Antidepressants |
Derma Range |
Nasal Sprays |
Inhalers |
|
Dry Powder Inhalers |
Syrups |
Antibiotics |
Ointments |
Creams and Lotions |
Scope
Amboxol is considered a high rotation product, ensuring consistent sales for distributors due to its high demand in hospitals, clinics and retail pharmacies, which are used in cough treatment, bronchitis and respiratory infections.
Profitability section
It is profitable for distributors because of high patient volume, repeat prescriptions and seasonal spike and this makes Amroxol a low-risk and high demand pharma product.
Trust factors
Strict quality is very important to ensure the quality and safety of the products. A manufacturer should follow:
Luckys Pharma has the authenticity to bestow patients and clients with top-notch pharma developments and devices. Also, it has become the topmost preference for many business associates who want to grow in the Indian pharma industry. Consider the following keynotes –
The Ambroxol 15mg segment shows strong growth potential due to the rising demand for cough and respiratory treatment in India. With the increasing pollution, lifestyle changes and a higher incidence of respiratory diseases. The high prescription rate, repeat usage and wide application in treating cough, bronchitis and respiratory infection and have a strong presence across hospitals, clinics and retail pharmacies ensure consistent demand in the market.
It is used to treat cough, bronchitis and respiratory tract disorders by thinning mucus and making it easier to expel.
It offers high prescription rates, repeat consumption and seasonal demand, which makes it a reliable and profitable product for pharma distributors.
Entrepreneurs with a valid GST and Drug license can start an Ambroxol PCD franchise. It is suitable for pharma distributors, medical store owners and startups.
A reliable manufacturer should have WHO-GMP and ISO certification and DCGI approval.
The future is strong due to increasing respiratory issues, expanding healthcare infrastructure and rising demand for effective cough treatments.